Research / KSCP / Fundamental state Inspectable configuration
State dimensions Filing 0001410578-23-002349 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
8.21% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
-0.09% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-208.87% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
156.48% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
95.04% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin 100th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
1.50% · CORE · VALID
Operating margin 88th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
-195.04% · CORE · VALID
R&D intensity 25th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
57.25% · OPTIONAL · VALID
SBC intensity 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
25.36% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/5 normalized Level 3 Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/6 normalized Level 3 Jun 30, 2022 0/6 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 4/9 normalized Level 3 Dec 31, 2023 6/9 normalized Level 3 Mar 31, 2024 5/7 normalized Level 3 Jun 30, 2024 5/7 normalized Level 3 Sep 30, 2024 7/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 15.32%
Current 8.21%
Delta -7.11% Capex Intensity Decreased
Previous 0.51%
Current -0.09%
Delta -0.60% Cash Generation Decreased
Previous -132.81%
Current -208.87%
Delta -76.07% Growth Decreased
Previous 241.94%
Current 156.48%
Delta -85.46% Inventory Pressure Increased
Previous 74.96%
Current 95.04%
Delta 20.07% Margin Increased
Previous 0.25%
Current 1.50%
Delta 1.25% Profitability Decreased
Previous -166.85%
Current -195.04%
Delta -28.18% R And D Intensity Increased
Previous 41.59%
Current 57.25%
Delta 15.66% Sbc Intensity Increased
Previous 20.52%
Current 25.36%
Delta 4.84% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.